STERIS plc (STE) — Fair Value Analysis

Base-case fair value (P50): $241.56 · Current price: $233.28 · Verdict: Fairly Valued

The Verdict on STE

Steris (STE) is currently assessed as Fairly Valued by our Monte Carlo simulations. With a median fair value (P50) projected at $241.56, the stock presently trades at $233.28, indicating a slight +3.5% to our P50 estimate. This outcome suggests that, based on our thousands of forward-looking scenarios, STE's current market price closely aligns with its intrinsic valuation, offering limited immediate upside or downside from a median perspective. The Fairly Valued verdict provides a clear benchmark for investors evaluating Steris's current market position against its simulated future potential.

How STE stacks up against Healthcare

Within the Healthcare sector, Steris (STE) maintains an average quality tier, reflecting its operational and financial health relative to its industry peers. This average quality assessment is a key input into our Monte Carlo modeling, influencing the range and probability of potential future outcomes for $233.28. While some sector peers might exhibit superior or inferior quality characteristics, STE's standing helps contextualize the simulation's results, anchoring its $241.56 around a mid-tier performance expectation. The analysis accounts for these sector dynamics in arriving at the +3.5% figure.

What this means for investors

For investors, the Fairly Valued verdict for STE, coupled with its +3.5% to the P50 of $241.56, suggests that the stock is neither significantly cheap nor expensive at its current price of $233.28. While an average quality tier implies stable underlying fundamentals, significant alpha generation may require a catalyst beyond current projections. To understand the full spectrum of possibilities, including specific bear-case and bull-case scenarios derived from our Monte Carlo distribution, investors are encouraged to explore FairCurve. Sign up for a free FairCurve account to see the full bear/bull distribution and track STE's fair value as new fundamentals are released.